India's vaccine output likely to fall short of target, sources say
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
WEDNESDAY, MAY 25, 2022
WEDNESDAY, MAY 25, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
India's vaccine output likely to fall short of target, sources say

Coronavirus chronicle

Reuters
20 May, 2021, 06:35 pm
Last modified: 20 May, 2021, 06:40 pm

Related News

  • India restricts sugar exports at 10 million tonnes
  • Worry as India to limit sugar export
  • Tata Steel says India export tax could alter output targets
  • India’s billionaire race sees one tycoon pulling away
  • India says 'substantive outcomes' from Biden, Modi talks

India's vaccine output likely to fall short of target, sources say

Lower-than-expected production could delay India's plans to vaccinate all its adults this year, amid fears the country will face another surge of coronavirus infections in the winter

Reuters
20 May, 2021, 06:35 pm
Last modified: 20 May, 2021, 06:40 pm
FILE PHOTO: A policeman asks people who came to receive a dose of a coronavirus vaccine to leave as they stand outside the gate of a vaccination centre which was closed due to unavailability of the supply of COVID-19 vaccine, in Mumbai, India. REUTERS/Francis Mascarenhas/File Photo
FILE PHOTO: A policeman asks people who came to receive a dose of a coronavirus vaccine to leave as they stand outside the gate of a vaccination centre which was closed due to unavailability of the supply of COVID-19 vaccine, in Mumbai, India. REUTERS/Francis Mascarenhas/File Photo

India's output of Covid-19 shots for August-December is likely to be lower than the government's public estimate, according to internal projections shared with Reuters by two sources.

Lower-than-expected production could delay India's plans to vaccinate all its adults this year, amid fears the country will face another surge of coronavirus infections in the winter. India's ongoing second wave, the world's worst since the pandemic began, has overwhelmed its health system. read more

The government last week publicly estimated 1.46 billion doses of its three approved shots - AstraZeneca, Sputnik V and Covaxin - would be made between August and December.

Production of the AstraZeneca vaccine, of which the Serum Institute of India (SII) is the biggest maker in the world, is expected to reach 100 million to 110 million doses a month from July and stay at that level for the foreseeable future, a source with knowledge of the matter said.

That would be at least 200 million doses less than the government's public forecast of 750 million AstraZeneca doses for the last five months of the year, a 27% shortfall.

An internal government projection for August and September shared by a second source put the monthly number of AstraZeneca doses at 100 million, out of 200 million for all the three approved shots combined.

The sources declined to be named discussing a subject on which Prime Minister Narendra Modi's government has been criticised due to a shortage of vaccines. Immunisations have fallen sharply since an April peak.

The Ministry of Health and Family Welfare did not respond to queries from Reuters.

SII, which is facing raw material shortages for another vaccine that the government is banking on, declined to comment.

A spokeswoman for Covaxin-maker Bharat Biotech said that last month the company raised its annual production capacity to more than 500 million doses, or about 42 million doses a month. It has been producing about 10 million doses a month.

Dr. Reddy's Laboratories, the local distributor for Russia's Sputnik V, did not respond to a request for comment.

Apart from the approved vaccines, the government has also forecast August-December production of 866 million doses of five yet-to-be-approved vaccines. Overall, the government has pledged to make 2.67 billion doses available this year.

SII has already halted exports until the end of the year to meet domestic demand, in a major blow to dozens of poor countries relying on it for supplies. read more

India has so far administered 187 million vaccine doses, the most after China and the United States, but fully immunised only about 3% of its 1.35 billion people.

World+Biz

India / Covid-19 vaccine production / Covid-19 vaccines / Vaccine Production / Serum Institute of India (SII) / AstraZeneca / Sputnik V / Dr Reddy's Laboratories

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A labourer carries a sack filled with sugar to load it onto a supply truck at a wholesale market in Kolkata, India, November 14, 2018. REUTERS/Rupak De Chowdhuri
    India restricts sugar exports at 10 million tonnes
  • Photo: Noor-A-Alam
    How fixed rate regime makes Bangladesh Bank’s monetary tools ineffective
  • British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
    BII to invest $450m in Bangladesh in 5 years

MOST VIEWED

  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing urges millions to keep working from home amid Covid outbreak menace
  • Picture: PTI
    Saudi Arabia bans travel to India, 15 other countries over Covid outbreaks
  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Dynamic zero-Covid approach: China's choice to safeguard lives, underpin growth

Related News

  • India restricts sugar exports at 10 million tonnes
  • Worry as India to limit sugar export
  • Tata Steel says India export tax could alter output targets
  • India’s billionaire race sees one tycoon pulling away
  • India says 'substantive outcomes' from Biden, Modi talks

Features

Underlying problems such as school dropouts need to be addressed first before taking a legal route to stop child labour. Photo: Reuters

‘Child labour in a country like Bangladesh is primarily a development issue, not so much of enforcement’

17m | Panorama
The balcony railings of the Boro Sardar Bari in Sonargaon. Made of cast iron, these railings feature vertical posts with intricate designs on top. Photo: Noor-A-Alam

The evolution of railing and grille designs

23h | Habitat
A Russian army service member fires a howitzer during drills at the Kuzminsky range in the southern Rostov region, Russia January 26, 2022. REUTERS/Sergey Pivovarov/File Photo

3 months of Ukraine war : Miscalculations, resistance and redirected focus

1d | Analysis
Musk is denying the sexual harassment allegation that surfaced this week. Photo: Bloomberg

Elon Musk’s crazily banal week 

1d | Panorama

More Videos from TBS

When is the right time to invest?

When is the right time to invest?

27m | Videos
Bangladesh Bank relaxes rules to deal with dollar crisis

Bangladesh Bank relaxes rules to deal with dollar crisis

13h | Videos
Russia claims use of laser weapons, Ukraine denies

Russia claims use of laser weapons, Ukraine denies

13h | Videos
Celebrity Gallery in Rajshahi like Madame Tussauds

Celebrity Gallery in Rajshahi like Madame Tussauds

14h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

4
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

5
The reception is a volumetric box-shaped room that has two glass walls on both the front and back ends and the other two walls are adorned with interior plants, wood and aluminium screens. Photo: Noor-A-Alam
Habitat

The United House: Living and working inside nature

6
Illustration: TBS
Banking

Let taka slide

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab